U.S. limits use of J&J’s COVID-19 vaccine for adults on blood clot risks

(Reuters) – The U.S. Meals and Drug Administration (FDA) mentioned on Thursday it was limiting the usage of Johnson & Johnson’s COVID-19 vaccine for adults because of the danger of a uncommon blood clotting syndrome.

The J&J shot is allowed for these aged 18 and above and is among the three COVID-19 vaccines cleared to be used in america.

The company mentioned the J&J shot might be administered in instances the place licensed or authorized COVID-19 vaccines usually are not accessible or if a person is much less eager on utilizing the opposite two pictures.

The FDA mentioned its evaluation had decided that the chance of thrombosis with thrombocytopenia syndrome after the administration of the shot warrants limiting of the authorization.

J&J didn’t instantly reply to a Reuters request for remark.

(Reporting by Amruta Khandekar; Enhancing by Anil D’Silva)